Sanofi Aventis Sues Wockhardt Over Uroxatral Patent
Sanofi-Aventis has filed suit against Wockhardt Ltd. and its U.S. subsidiary, alleging that the Indian generics maker has infringed the patent for Sanofi prostate treatment Uroxatral....To view the full article, register now.
Already a subscriber? Click here to view full article